Orchid Pharma (BOM:524372) Days Sales Outstanding : 88.18 (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Orchid Pharma Days Sales Outstanding?

Orchid Pharma's average Accounts Receivable for the three months ended in Sep. 2024 was ₹2,152 Mil. Orchid Pharma's Revenue for the three months ended in Sep. 2024 was ₹2,227 Mil. Hence, Orchid Pharma's Days Sales Outstanding for the three months ended in Sep. 2024 was 88.18.

The historical rank and industry rank for Orchid Pharma's Days Sales Outstanding or its related term are showing as below:

BOM:524372' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.66 Med: 87.06 Max: 112.96
Current: 80.48

During the past 13 years, Orchid Pharma's highest Days Sales Outstanding was 112.96. The lowest was 33.66. And the median was 87.06.

BOM:524372's Days Sales Outstanding is ranked worse than
59.63% of 971 companies
in the Drug Manufacturers industry
Industry Median: 71.73 vs BOM:524372: 80.48

Orchid Pharma's Days Sales Outstanding increased from Sep. 2023 (86.12) to Sep. 2024 (88.18).

Orchid Pharma Days Sales Outstanding Historical Data

The historical data trend for Orchid Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Days Sales Outstanding Chart

Orchid Pharma Annual Data

Trend

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

70.86

82.59

99.89

105.72

91.52

Orchid Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															86.12	77.60	82.30	73.01	88.18

Competitive Comparison of Orchid Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orchid Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orchid Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orchid Pharma's Days Sales Outstanding falls into.

Orchid Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orchid Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (2151.938	+	1955.471)	/	2 )	/	8190.663	*	365
=	2053.7045					/	8190.663	*	365
=	91.52

Orchid Pharma's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0	+	2151.993)	/	1 )	/	2226.986	*	365 / 4
=	2151.993					/	2226.986	*	365 / 4
=	88.18

Orchid Pharma (BOM:524372) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orchid Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (BOM:524372) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

ORCHPHARMA:India

Address

Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines